May 29 (Reuters) - Virtual chronic care provider Omada

Health is targeting a valuation of about $1.1 billion in its

initial public offering in the United States, signaling a

comeback for capital markets after several months of slowdown in

listings.

The company said on Thursday it would sell 7.9 million

shares in a range of $18 to $20 per share, potentially fetching

up to $158 million if priced at the upper limit.

While U.S. President Donald Trump's tariff whiplash has

roiled markets and cast a shadow on new listings, companies in

sectors perceived as less sensitive to economic headwinds are

pushing ahead with their initial public offerings.

The San Francisco, California-based company, last raised

$192 million in a Series E funding round in 2022.

Omada has applied to list its common stock on the Nasdaq

under the symbol "OMDA".

J.P.Morgan, Goldman Sachs, Morgan Stanley and Barclays

are among the underwriters for Omada's offering.